Abstract
Clostridium histolyticum collagenase injection is a mini-invasive and new treatment for Dupuytren’s disease. It is used in the USA and in Europe as an alternative treatment to partial fasciectomy (Gilpin et al., J Hand Sur 35:2027–2038, 2010; Pajardi et al., Riv Chir Mano 50:5, 2013; Badalamente and Hurst, J Hand Surg Am 32:767–774, 2007; Thomas and Bayat, Therap Clin Risk Manag 6:557–572, 2010; Peimer et al., J Hand Surg 38:12–22, 2013)).
Upper limb surgery usually needs specifically rehabilitation and this technique too.
Edema, pain, hematoma, skin laceration, and even joint’s stiffness are some of the principal symptoms that patients normally have. Especially in these cases, it is important to take charge of the patient as soon as possible to have a better result.
The aim of this chapter is to show our rehabilitation approach after enzymatic fasciectomy for Dupuytren’s disease (Dupuytren, Lancet 2:222–225, 1834; Burge, Hand Clinics 15:63–71, 1999; Beck, Monatschr Unfallheilkd 57: 69–82, 1954)).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Dupuytren G. Permanent retraction of the fingers, produced by an affection of the palmar fascia. Lancet. 1834;2:222–5.
Burge P. Genetic of Dupuytren’s disease. Hand Clin. 1999;15(1):63–71.
Beck W. Untersuchungen über die Häufigkeit der Dupuytrenschen Kontraktur. Monatschr Unfallheilkd. 1954;57:69–82.
Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg. 2010;35(12):2027–38.
Pajardi G, Parolo C, Cavalli E, Ponti V. Collagenasi: report preliminare. Riv Chir Mano. 2013;50(1):5.
Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contracture. J Hand Surg Am. 2007;32(6):767–74.
Thomas A, Bayat A. The emerging role of clostridium histolyticum collagenase in the treatment of Dupuytren disease. Ther Clin Risk Manag. 2010;6:557–72.
Peimer CA, Blazar P, Coleman S, Thomas F, Kaplan D, Smith T, Tursi JP, Cohen B, Kaufman GJ, Lindau T. Dupuytren contracture relapse following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg. 2013;38(1):12–22.
Hurst LC, Badalamente M. Associated disease. In: McFarlane RM, McGrouther DA, Flint MH, editors. Dupuytren’s disease. Edinburgh: Churchill Livingstone; 1990. p. 253–60.
Conway H. Dupuytren’s contracture. Am J Surg. 1954;87:101–19.
Flint MH. Dupuytren’s disease. Edinburgh: Churchill Livingstone; 1990. p. 136–54.
Ghazi MR. Dupuytren disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. 2007;89(1):189–98.
Mackin EJ, Skirven TM. Hand therapy. In: Tubiana R, Leclercq C, Hurst LC, Badalamente MA, Mackin EJ, editors. Dupuytren’s disease. London: Martin Dunitz Ltd; 2000. p. 251–63.
Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren’s disease: 8-year follow-up. J Hand Surg Am. 2010;35(4):534–9.
Engstrand C, Krevers B, Kvist J. Factors affecting functional recovery after surgery and hand therapy in patient with Dupuytren’s disease. J Hand Ther. 2015;28(3):255–60.
Rodriguez J, Becker G, Ball C, Zhang W, Giele H, Hobby J, Pratt A, Davis T. Surgery for Dupuytren’s contracture of the finger. Cochrane Database Syst Rev. 2015;(12):CD010143. https://doi.org/10.1002/14651858.CD010143.pub2.
Evans R. Therapeutic management of Dupuytren’s contracture. In:Rehabilitation of hand and upper extremity, vol. 1. 6th ed. Philadelphia: Mosby Elsevier; 2011.
Herweijer H, Dijkstra UP, Nicolai JA, van der Sluis CK. Postoperative hand therapy in Dupuytren’s disease. Disabil Rehabil. 2007;29(22):1736–41.
Shaunak SD, Vincent RH. The treatment of Dupuytren disease. J Hand Surg. 2011;36(5):936–42.
Larson D, Jerosch-Herold C. Clinical effectiveness of post-operative splinting after surgical release of Dupuytren’s contracture: a systematic review. BMC Musculoskelet Disord. 2008;9:104.
Warwick D, Pajardi G. Dupuytren’s disease. Fessh instructional course. Torino: CG Ed Medico Scientifiche; 2015.
Gontran RS. Fasciectomy for treatment of Dupuytren’s disease and early complications. J Hand Surg. 1990;15(5):755–61.
Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren’s contracture surgery. J Hand Surg. 2005;30(5):1021–5.
Berto GM, Filistad E, Menegari A, di Dupuytren M, Pajardi G. Chirurgia e riabilitazione della mano. Padua: Piccin; 2014. p. 337–52.
Zyluk A, Jagielski W. The effect of the severity of the Dupuytren’s contracture on the function of the hand before and after surgery. J Hand Surg. 2007;32(3):326–9.
Tocco S, Pedrazzini A, Pogliacomi S. Clinical approach in PIPJ flexion contracture conservative treatment: our experience. Off J Soc Med Nat Sci Parma. 2016;87(1-S):101–11.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Seppi, S., Mancon, E.M., Pagliaro, R. (2018). Rehabilitation After Treatment. In: Pajardi, G., Badalamente, M., Hurst, L. (eds) Collagenase in Dupuytren Disease . Springer, Cham. https://doi.org/10.1007/978-3-319-65822-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-65822-3_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65821-6
Online ISBN: 978-3-319-65822-3
eBook Packages: MedicineMedicine (R0)